Origen de la red de primer grado John Garcia.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 34 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a John Garcia a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal Human Resources Officer | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| SAGE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Boston College | College/University | Graduate Degree Undergraduate Degree | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Corporate Officer/Principal | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| SANOFI | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Secretary | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Founder Chief Executive Officer | |
Abide Therapeutics, Inc.
 Abide Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Other | Founder Founder | |
CHP Management, Inc.
 CHP Management, Inc. Investment ManagersFinance CHP Management Inc (Cardinal Partners) is a venture capital firm founded in 1996 by John K Clarke, Brandon H Hull and John J Park. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor Founder | |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Human Resources Officer Compliance Officer | |
Alnylam UK Ltd.
 Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The company is based in Maidenhead, UK. | Biotechnology | Director/Board Member Director/Board Member | |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer | |
The British United Provident Association Ltd.
 The British United Provident Association Ltd. Life/Health InsuranceFinance The British United Provident Association Ltd. provides healthcare products and services. It offers health, dental and travel insurance, optical and audiology, and care homes. The company was founded on April 3, 1947 and is headquartered in London, the United Kingdom. | Life/Health Insurance | Sales & Marketing | |
| University of California, Berkeley | College/University | Masters Business Admin | |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Pharmaceuticals: Major | Director/Board Member | |
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Founder | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Sales & Marketing | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Ohmeda Pharmaceuticals | Corporate Officer/Principal | ||
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
| KRYSTAL BIOTECH, INC. | Biotechnology | Director/Board Member | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Director/Board Member | |
Alnylam Germany GmbH
 Alnylam Germany GmbH BiotechnologyHealth Technology Part of Alnylam Pharmaceuticals, Inc., Alnylam Germany GmbH is a company that is leading the translation of RNA Interference (RNAi) into a completely innovative class of medicines, which they believe have the potential to transform the lives of patients with genetic and rare diseases. The company is based in Munich, Germany. The CEOs of the company are David Ronald Jones, Hannes Schmeil, Theresa Marie Heggie. The text in the company's description is in German, but it appears to emphasize the importance of clinical trials in developing new medicines and highlights the company's use of RNAi technology to help patients with limited treatment options. | Biotechnology | Chief Executive Officer | |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
| FREELINE THERAPEUTICS HOLDINGS PLC | Biotechnology | Chief Executive Officer | |
| ACCELERON PHARMA INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SAINT JEAN GROUPE | Food: Major Diversified | Director/Board Member | |
| Medical University of South Carolina | College/University | Doctorate Degree | |
| REVO BIOLOGICS INC | Biotechnology | Corporate Officer/Principal | |
| University of Arizona | College/University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 39 |
| Reino Unido | 5 |
| Francia | 3 |
| Alemania | 3 |
| Irlanda | 2 |
Sectorial
| Health Technology | 36 |
| Consumer Services | 8 |
| Finance | 4 |
| Commercial Services | 3 |
| Retail Trade | 2 |
Operativa
| Director/Board Member | 112 |
| Corporate Officer/Principal | 84 |
| Independent Dir/Board Member | 34 |
| Undergraduate Degree | 30 |
| Founder | 23 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Paul Schimmel | 31 |
| John Clarke | 30 |
| Olivier Brandicourt | 23 |
| Margaret Hamburg | 22 |
| Kevin Starr | 19 |
| Barry Greene | 18 |
| Theresa Heggie | 16 |
| David-Alexandre Gros | 13 |
| Manmeet Singh Soni | 13 |
| Jing Marantz | 12 |
| Karen Anderson | 12 |
| Colleen Reitan | 10 |
| Laura Sepp-Lorenzino | 9 |
| Jeffrey Poulton | 9 |
| Peter F. Smith | 8 |
- Bolsa de valores
- Insiders
- John Garcia
- Conexiones Empresas
